| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Fin. & Operating Officer | Chief Operating Officer | See Remarks
2 companies
Robert Matthew Lutz is Chief Fin. & Operating Officer at SVRA, with reported holdings spanning 2 companies. Robert Matthew Lutz's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.6M at current prices.
Robert Matthew Lutz's largest disclosed position is in SVRA as Chief Fin. & Operating Officer, worth about $1.6M.
Robert Matthew Lutz has 11 Form 4 filings on record from March 2021 to July 2026, across 2 companies: Chief Fin. & Operating Officer at Savara (SVRA), 2023–2026; iBio (IBIO), 2021–2022.
The 16 reported transactions were 7 option or other derivative awards, 6 stock awards, 2 tax withholdings and 1 open-market sale.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $9K.
The only open-market sale was 24,625 shares of IBIO at an average $0.35 on March 10, 2022, about $9K. Twelve months later IBIO was down 79%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2022 | IBIO Ibio, Inc. | See Remarks | Sell | 24,625 | $0.35 | $8,510.40 | -10.6% | -17.8% | -78.5% |